Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Trading exchanges
Trading exchanges
NASDAQ
Products 51 to 60 of 69
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Project Cyborg
by
Autodesk
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Design
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ADSK
(NASDAQ)
Value chain stage:
Platform
rHuPH20
by
Halozyme
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:37 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Input
Self-Limiting Diamondback Moth
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
+
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Fall Armyworm
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Ecosystem Restoration
+
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Medfly
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Self-Limiting Spotted-Wing Drosophila
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:53 (5 years ago)
Date last modified:
2019/09/12 14:53 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Animal
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
SentryBox
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
North America
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:02 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
SigNature DNA
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Turkey
+
Africa
+
UK
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:01 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
SigNature T
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/01/30 12:00 (6 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
Sitagliptin
by
Codexis
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
CDXS
(NASDAQ)
Value chain stage:
Input
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
